Education
About Us
Working with TipRanks
Follow Us
AIM ImmunoTech (AIM)
:AIM
Rintatolimod
Long Covid, Post Covid-19 Condition
Phase II
Completed
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Oct 20, 2022
―
Rintatolimod
Pancreatic Cancer
Phase II
Suspended
Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC
Aug 08, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AIM ImmunoTech (AIM) have in its pipeline
AIM is currently developing the following drugs: Rintatolimod, Rintatolimod. These drug candidates are in various stages of clinical development as the company works toward FDA approval.